Homozygous Familial Hypercholesterolemia Market is driven by...

a adăugat un sunet Health

2025-06-02 13:26:56 -

Homozygous Familial Hypercholesterolemia Market is driven by innovative lipid-lowering therapies

Homozygous familial hypercholesterolemia (HoFH) is an inherited disorder characterized by extremely high low-density lipoprotein cholesterol (LDL-C) levels from birth, leading to early onset atherosclerosis and cardiovascular complications. The HoFH market comprises specialized therapeutics such as PCSK9 inhibitors, microsomal triglyceride transfer protein (MTP) inhibitors, antisense...

0 Commentarii 0 Distribuiri 592 Views 0 previzualizare